Commentary

ESC13 Reporter's Notebook: ESC Congress 2013 Wrap Up

Publish date: September 10, 2013

 

IMNG Medical News reporter Bruce Jancin brings you some of the highlights of the 2013 ESC Congress in Amsterdam -- from bikes to practice-changing studies.

Recommended Reading

Saxagliptin, alogliptin show cardiovascular safety in randomized trials
MDedge Internal Medicine
Aliskiren fails to fight coronary atherosclerosis
MDedge Internal Medicine
Edoxaban pivotal trial shows VTE efficacy, safety
MDedge Internal Medicine
Undetected silent AF is present in 3% of 75-year-olds
MDedge Internal Medicine
Cardiovascular ‘polypill’ improved medication adherence, hypertension
MDedge Internal Medicine
Rate of avoidable heart disease deaths highest in blacks
MDedge Internal Medicine
New heart failure inotrope could be ‘Holy Grail’
MDedge Internal Medicine
CRT appears deadly in short-QRS patients
MDedge Internal Medicine
Fibroblast growth factor 21 promising in treating metabolic disorders
MDedge Internal Medicine
ESC13 Commentary: More studies link smoking and heart disease
MDedge Internal Medicine